BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 38170396)

  • 1. Competing risk nomogram and risk classification system for evaluating overall and cancer-specific survival in neuroendocrine carcinoma of the cervix: a population-based retrospective study.
    Liu J; Lyu Y; He Y; Ge J; Zou W; Liu S; Yang H; Li J; Jiang K
    J Endocrinol Invest; 2024 Jun; 47(6):1545-1557. PubMed ID: 38170396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and validation of the prognostic model for patients with neuroendocrine cervical carcinoma: a competing risk nomogram analysis.
    Jiang AG; Cai X
    BMC Cancer; 2022 Jan; 22(1):4. PubMed ID: 34980030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a nomogram for predicting cancer-specific survival in small-bowel adenocarcinoma patients using the SEER database.
    Xu D; He Y; Liao C; Tan J
    World J Surg Oncol; 2024 Jun; 22(1):151. PubMed ID: 38849854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.
    Feng Y; Wang Y; Xie Y; Wu S; Li Y; Li M
    BMC Cancer; 2021 Apr; 21(1):450. PubMed ID: 33892663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of nomograms for predicting overall survival and cancer specific survival in locally advanced breast cancer patients: A SEER population-based study.
    Yin F; Wang S; Hou C; Zhang Y; Yang Z; Wang X
    Front Public Health; 2022; 10():969030. PubMed ID: 36203704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel prognostic model predicting the long-term cancer-specific survival for patients with hypopharyngeal squamous cell carcinoma.
    Tang X; Pang T; Yan WF; Qian WL; Gong YL; Yang ZG
    BMC Cancer; 2020 Nov; 20(1):1095. PubMed ID: 33176731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer-specific survival of patients with kidney cancer.
    Zhou Y; Zhang R; Ding Y; Wang Z; Yang C; Tao S; Liang C
    Cancer Med; 2020 Apr; 9(8):2710-2722. PubMed ID: 32087609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and validation of nomogram models for overall survival and cancer-specific survival in spindle cell sarcoma patients.
    Qi W; Ren Y; Wang H; Wan Y; Wang D; Yao J; Pan H
    Sci Rep; 2023 Dec; 13(1):23018. PubMed ID: 38155261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic models for predicting overall and cancer-specific survival of patients with initially diagnosed metastatic cervical squamous cell carcinoma: A study based on SEER database.
    Ding R; Su Z; Chen M; Chen L
    Medicine (Baltimore); 2023 Jul; 102(28):e34313. PubMed ID: 37443499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic nomogram predicts overall survival in pulmonary large cell neuroendocrine carcinoma.
    He Y; Liu H; Wang S; Chen Y
    PLoS One; 2019; 14(9):e0223275. PubMed ID: 31560723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of nomograms and risk stratification systems to predict the overall survival and cancer-specific survival of patients with hepatocellular carcinoma.
    Kang X; Liu X; Li Y; Yuan W; Xu Y; Yan H
    Clin Exp Med; 2024 Feb; 24(1):44. PubMed ID: 38413421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of prognostic nomograms for early-onset colon cancer in different tumor locations: a population-based study.
    Zhu S; Tu J; Pei W; Zheng Z; Bi J; Feng Q
    BMC Gastroenterol; 2023 Oct; 23(1):362. PubMed ID: 37865754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A practical nomogram and risk stratification system predicting the cancer-specific survival for patients with early hepatocellular carcinoma.
    Yan B; Su BB; Bai DS; Qian JJ; Zhang C; Jin SJ; Jiang GQ
    Cancer Med; 2021 Jan; 10(2):496-506. PubMed ID: 33280269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing prognostic accuracy: a SEER-based analysis for overall and cancer-specific survival prediction in cervical adenocarcinoma patients.
    Chen L; Chen Y; Shi H; Cai R
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17027-17037. PubMed ID: 37747524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of Nomograms to Predict Cancer-Specific Survival and Overall Survival in Elderly Patients With Prostate Cancer: A Population-Based Study.
    Zhang Z; Zhanghuang C; Wang J; Tian X; Wu X; Li M; Mi T; Liu J; Jin L; Li M; He D
    Front Oncol; 2022; 12():918780. PubMed ID: 35814387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of surgery and radiotherapy in elderly patients with localized prostate cancer: establishing and time-based external validation a nomogram from SEER-based study.
    Zhanghuang C; Zhu J; Li Y; Wang J; Ma J; Li L; Yao Z; Ji F; Wu C; Tang H; Xie Y; Yan B; Yang Z
    BMC Urol; 2024 Jan; 24(1):12. PubMed ID: 38184526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer.
    Shi X; Xu L; Ma B; Wang S
    Sci Rep; 2020 Aug; 10(1):14143. PubMed ID: 32839498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Factors and a Nomogram Predicting Overall Survival and Cancer-Specific Survival for Patients with Collecting Duct Renal Cell Carcinoma.
    Xiao R; Liu C; He W; Ma L
    Biomed Res Int; 2021; 2021():6736008. PubMed ID: 34805402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two web-based dynamically interactive nomograms and risk stratification systems for predicting survival outcomes and guiding treatment in non-metastatic nasopharyngeal carcinoma.
    Zuo H; Li MM
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15969-15987. PubMed ID: 37684510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a nomogram to predict long-term cancer-specific survival for patients with osteosarcoma.
    Yu Y; Wang S; Liu J; Ge J; Guan H
    Sci Rep; 2023 Jun; 13(1):10230. PubMed ID: 37353555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.